Back
Climb Bio, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CLYM
Climb Bio, Inc.
Last Price:
$6.56
Seasonality Move:
23.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and CLYM is experiencing selling pressure, which indicates risk of future bearish movement.
Climb Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.84 | Sell |
| 20-day SMA: | 6.95 | Sell |
| 50-day SMA: | 6.22 | Buy |
| 200-day SMA: | 3.25 | Buy |
| 8-day EMA: | 6.79 | Sell |
| 20-day EMA: | 6.79 | Sell |
| 50-day EMA: | 6.16 | Buy |
| 200-day EMA: | 4.04 | Buy |
Climb Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 48.01 | Sell |
| Chaikin Money Flow: | -286521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.7 - 7.3) | Sell |
| Bollinger Bands (100): | (2.74 - 6.58) | Buy |
Climb Bio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Climb Bio, Inc. Stock
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 6.56 while CLYM 8-day simple moving average is 6.84, which is a Sell signal.
-
The stock price of CLYM is 6.56 while Climb Bio, Inc. 20-day SMA is 6.95, which makes it a Sell.
-
Climb Bio, Inc. 50-day simple moving average is 6.22 while CLYM share price is 6.56, making it a Buy technically.
-
CLYM stock price is 6.56 and Climb Bio, Inc. 200-day simple moving average is 3.25, creating a Buy signal.
CLYM Technical Analysis vs Fundamental Analysis
Buy
56
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. a Buy or a Sell?
-
Climb Bio, Inc. stock is rated a BuyThe current Climb Bio, Inc. [CLYM] share price is $6.56. The Score for CLYM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Climb Bio, Inc. Stock Info
Market Cap:
295.8M
Price in USD:
6.56
Share Volume:
440.8K
Climb Bio, Inc. 52-Week Range
52-Week High:
8.04
52-Week Low:
1.05
Buy
56
Climb Bio, Inc. (CLYM)
is a Buy
Climb Bio, Inc. Share Price Forecast
-
What is the Climb Bio, Inc. stock price today?The Climb Bio, Inc. stock price is 6.56 USD today.
-
Will CLYM stock go up or go down?Climb Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Climb Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Climb Bio, Inc. is not overvalued.
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 6.56 while CLYM 8-day exponential moving average is 6.79, which is a Sell signal.
-
The stock price of CLYM is 6.56 while Climb Bio, Inc. 20-day EMA is 6.79, which makes it a Sell.
-
Climb Bio, Inc. 50-day exponential moving average is 6.16 while CLYM share price is 6.56, making it a Buy technically.
-
CLYM stock price is 6.56 and Climb Bio, Inc. 200-day simple moving average is 4.04, creating a Buy signal.
Fundamental Analysis of Climb Bio, Inc.
Is Climb Bio, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Climb Bio, Inc.
Should I short Climb Bio, Inc. stock?
-
CLYM Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Climb Bio, Inc. is a Buy
-
Climb Bio, Inc. Relative Strength Index (RSI) is 48.01, which suggest Climb Bio, Inc. is oversold
-
The Bollinger Bands (25) for Climb Bio, Inc. is (6.7 - 7.3), which suggest Climb Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Climb Bio, Inc. is (2.74 - 6.58), which suggest Climb Bio, Inc. is a Buy
* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.